These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 29766838)

  • 1. DMD mutation and LTBP4 haplotype do not predict onset of left ventricular dysfunction in Duchenne muscular dystrophy.
    Van Dorn CS; Puchalski MD; Weng HY; Bleyl SB; Butterfield RJ; Williams RV
    Cardiol Young; 2018 Jul; 28(7):910-915. PubMed ID: 29766838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The IAAM LTBP4 Haplotype is Protective Against Dystrophin-Deficient Cardiomyopathy.
    Bello L; Sabbatini D; Fusto A; Gorgoglione D; Borin GU; Penzo M; Riguzzi P; Villa M; Vianello S; Calore C; Melacini P; Vio R; Barp A; D'Angelo G; Gandossini S; Politano L; Berardinelli A; Messina S; Vita GL; Pedemonte M; Bruno C; Albamonte E; Sansone V; Baranello G; Masson R; Astrea G; D'Amico A; Bertini E; Pane M; Lucibello S; Mercuri E; Spurney C; Clemens P; Morgenroth L; Gordish-Dressman H; McDonald CM; Hoffman EP; ; Pegoraro E
    J Neuromuscul Dis; 2024; 11(2):285-297. PubMed ID: 38363615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LTBP4 genotype predicts age of ambulatory loss in Duchenne muscular dystrophy.
    Flanigan KM; Ceco E; Lamar KM; Kaminoh Y; Dunn DM; Mendell JR; King WM; Pestronk A; Florence JM; Mathews KD; Finkel RS; Swoboda KJ; Gappmaier E; Howard MT; Day JW; McDonald C; McNally EM; Weiss RB;
    Ann Neurol; 2013 Apr; 73(4):481-8. PubMed ID: 23440719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Modifiers of Duchenne Muscular Dystrophy and Dilated Cardiomyopathy.
    Barp A; Bello L; Politano L; Melacini P; Calore C; Polo A; Vianello S; Sorarù G; Semplicini C; Pantic B; Taglia A; Picillo E; Magri F; Gorni K; Messina S; Vita GL; Vita G; Comi GP; Ermani M; Calvo V; Angelini C; Hoffman EP; Pegoraro E
    PLoS One; 2015; 10(10):e0141240. PubMed ID: 26513582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular dysfunction in duchenne muscular dystrophy and genotype.
    Ashwath ML; Jacobs IB; Crowe CA; Ashwath RC; Super DM; Bahler RC
    Am J Cardiol; 2014 Jul; 114(2):284-9. PubMed ID: 24878125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac Dysfunction in Duchenne Muscular Dystrophy Is Less Frequent in Patients With Mutations in the Dystrophin Dp116 Coding Region Than in Other Regions.
    Yamamoto T; Awano H; Zhang Z; Sakuma M; Kitaaki S; Matsumoto M; Nagai M; Sato I; Imanishi T; Hayashi N; Matsuo M; Iijima K; Saegusa J
    Circ Genom Precis Med; 2018 Jan; 11(1):e001782. PubMed ID: 29874176
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Kosac A; Pesovic J; Radenkovic L; Brkusanin M; Radovanovic N; Djurisic M; Radivojevic D; Mladenovic J; Ostojic S; Kovacevic G; Kravljanac R; Savic Pavicevic D; Milic Rasic V
    Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Study of Exon Variants in the NF-κB and TGFβ Pathways Identifies CD40 as a Modifier of Duchenne Muscular Dystrophy.
    Bello L; Flanigan KM; Weiss RB; ; Spitali P; Aartsma-Rus A; Muntoni F; Zaharieva I; Ferlini A; Mercuri E; Tuffery-Giraud S; Claustres M; Straub V; Lochmüller H; Barp A; Vianello S; Pegoraro E; Punetha J; Gordish-Dressman H; Giri M; McDonald CM; Hoffman EP;
    Am J Hum Genet; 2016 Nov; 99(5):1163-1171. PubMed ID: 27745838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-range genomic regulators of THBS1 and LTBP4 modify disease severity in duchenne muscular dystrophy.
    Weiss RB; Vieland VJ; Dunn DM; Kaminoh Y; Flanigan KM;
    Ann Neurol; 2018 Aug; 84(2):234-245. PubMed ID: 30014611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of genetic modifiers for Duchenne muscular dystrophy: a multicentre study assessing SPP1 and LTBP4 variants.
    van den Bergen JC; Hiller M; Böhringer S; Vijfhuizen L; Ginjaar HB; Chaouch A; Bushby K; Straub V; Scoto M; Cirak S; Humbertclaude V; Claustres M; Scotton C; Passarelli C; Lochmüller H; Muntoni F; Tuffery-Giraud S; Ferlini A; Aartsma-Rus AM; Verschuuren JJ; 't Hoen PA; Spitali P
    J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1060-5. PubMed ID: 25476005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pan HDAC inhibitor Givinostat improves muscle function and histological parameters in two Duchenne muscular dystrophy murine models expressing different haplotypes of the LTBP4 gene.
    Licandro SA; Crippa L; Pomarico R; Perego R; Fossati G; Leoni F; Steinkühler C
    Skelet Muscle; 2021 Jul; 11(1):19. PubMed ID: 34294164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Milder course in Duchenne patients with nonsense mutations and no muscle dystrophin.
    Zatz M; Pavanello RC; Lazar M; Yamamoto GL; Lourenço NC; Cerqueira A; Nogueira L; Vainzof M
    Neuromuscul Disord; 2014 Nov; 24(11):986-9. PubMed ID: 25047667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial application of three-dimensional speckle-tracking echocardiography to detect subclinical left ventricular dysfunction and stratify cardiomyopathy associated with Duchenne muscular dystrophy in children.
    Yu HK; Xia B; Liu X; Han C; Chen W; Li Z
    Int J Cardiovasc Imaging; 2019 Jan; 35(1):67-76. PubMed ID: 30105418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-Glycanated Biglycan and LTBP4: Leveraging the extracellular matrix for Duchenne Muscular Dystrophy therapeutics.
    Fallon JR; McNally EM
    Matrix Biol; 2018 Aug; 68-69():616-627. PubMed ID: 29481844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy.
    Jefferies JL; Eidem BW; Belmont JW; Craigen WJ; Ware SM; Fernbach SD; Neish SR; Smith EO; Towbin JA
    Circulation; 2005 Nov; 112(18):2799-804. PubMed ID: 16246949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular function and response to enalapril in patients with duchenne muscular dystrophy during the second decade of life.
    Ramaciotti C; Heistein LC; Coursey M; Lemler MS; Eapen RS; Iannaccone ST; Scott WA
    Am J Cardiol; 2006 Sep; 98(6):825-7. PubMed ID: 16950195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterozygous Cystic Fibrosis Transmembrane Regulator Gene Missense Variants Are Associated With Worse Cardiac Function in Patients With Duchenne Muscular Dystrophy.
    Jiang X; Shao Y; Araj FG; Amin AA; Greenberg BM; Drazner MH; Xing C; Mammen PPA
    J Am Heart Assoc; 2020 Oct; 9(19):e016799. PubMed ID: 33003980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Early Left Ventricular Dysfunction in Patients with Duchenne Muscular Dystrophy Using Two-Dimensional Speckle Tracking Echocardiography and Tissue Doppler Imaging.
    Cho MJ; Lee JW; Lee J; Shin YB
    Pediatr Cardiol; 2018 Dec; 39(8):1614-1619. PubMed ID: 30003298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic modifiers of ambulation in the Cooperative International Neuromuscular Research Group Duchenne Natural History Study.
    Bello L; Kesari A; Gordish-Dressman H; Cnaan A; Morgenroth LP; Punetha J; Duong T; Henricson EK; Pegoraro E; McDonald CM; Hoffman EP;
    Ann Neurol; 2015 Apr; 77(4):684-96. PubMed ID: 25641372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left Ventricular Magnetic Resonance Imaging Strain Predicts the Onset of Duchenne Muscular Dystrophy-Associated Cardiomyopathy.
    Siddiqui S; Alsaied T; Henson SE; Gandhi J; Patel P; Khoury P; Villa C; Ryan TD; Wittekind SG; Lang SM; Taylor MD
    Circ Cardiovasc Imaging; 2020 Nov; 13(11):e011526. PubMed ID: 33190531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.